Drug Profile
Research programme: fibromyalgia therapies - Cypress Bioscience/Georgetown University
Latest Information Update: 11 Jan 2008
Price :
$50
*
At a glance
- Originator Cypress Bioscience; Georgetown University School of Medicine
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Fibromyalgia
Most Recent Events
- 02 Apr 2001 Preclinical development for Fibromyalgia in USA (Unknown route)